Timothy B. Lowinger
2019
In 2019, Timothy B. Lowinger earned a total compensation of $873.4K as Chief Science and Technology Officer at Mersana Therapeutics, a 17% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $173,140 |
---|---|
Option Awards | $139,764 |
Salary | $393,500 |
Stock Awards | $160,000 |
Other | $7,000 |
Total | $873,404 |
Lowinger received $393.5K in salary, accounting for 45% of the total pay in 2019.
Lowinger also received $173.1K in non-equity incentive plan, $139.8K in option awards, $160K in stock awards and $7K in other compensation.
Rankings
In 2019, Timothy B. Lowinger's compensation ranked 9,865th out of 13,971 executives tracked by ExecPay. In other words, Lowinger earned more than 29.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,865 | 29th |
Manufacturing | 3,984 | 30th |
Chemicals And Allied Products | 1,518 | 31st |
Drugs | 1,298 | 31st |
Pharmaceutical Preparations | 965 | 31st |
Lowinger's colleagues
We found four more compensation records of executives who worked with Timothy B. Lowinger at Mersana Therapeutics in 2019.
News
Mersana Therapeutics CEO Anna Protopapas' 2023 pay jumps 56% to $4.5M
April 26, 2024
Mersana Therapeutics CEO Anna Protopapas' 2022 pay falls 66% to $2.8M
April 28, 2023
Mersana Therapeutics CEO Anna Protopapas' 2021 pay jumps 226% to $8.3M
April 29, 2022
Mersana Therapeutics Chief Medical Officer Arvin Yang receives $4.5M in 2020
April 27, 2021
Mersana Therapeutics CEO Anna Protopapas' 2019 pay falls 33% to $1.7M
April 20, 2020
Mersana Therapeutics CEO Anna Protopapas' 2018 pay jumps 184% to $2.6M
April 23, 2019